Concord Biotech

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue226.11320.21258.95439.26217.67
Expenses147.94186.92159.63254.18160.43
EBITDA91.59146.70112.68199.8175.08
EBIT78.41133.3999.42185.1957.30
Profit Before Tax78.17133.2999.32185.1057.24
Net Profit58.2498.7074.09141.9442.57
Financial Ratios
Operating Profit Margin42.44%47.30%46.14%46.48%36.80%
Net Profit Margin26.99%31.82%30.34%33.02%20.87%
Earning Per Share (Diluted)5.579.437.0813.574.07
Dividends Per Share0.000.000.000.000.00